Literature DB >> 22248531

Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death.

Iris C R M Kolder1, Michael W T Tanck, Connie R Bezzina.   

Abstract

Sudden cardiac death (SCD) is a prevalent cause of death in Western societies. Genome-wide association studies (GWAS) conducted over the last few years have uncovered common genetic variants modulating risk of SCD. Furthermore, GWAS studies uncovered several loci impacting on heart rate and ECG indices of conduction and repolarization, as measures of cardiac electrophysiological function and likely intermediate phenotypes of SCD risk. We here review these recent developments and their implications for the identification of novel molecular pathways underlying normal electrophysiological function and susceptibility to SCD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22248531     DOI: 10.1016/j.yjmcc.2011.12.014

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  23 in total

Review 1.  Genetic variations involved in sudden cardiac death and their associations and interactions.

Authors:  Dazhen Wei; Luyuan Tao; Mingyuan Huang
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 2.  Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders

Authors:  Marina Cerrone; Carol Ann Remme; Rafik Tadros; Connie R Bezzina; Mario Delmar
Journal:  Circulation       Date:  2019-08-12       Impact factor: 29.690

Review 3.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

4.  Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics.

Authors:  Pieter G Postema; Jon Neville; Jonas S S G de Jong; Klaus Romero; Arthur A M Wilde; Raymond L Woosley
Journal:  Europace       Date:  2013-03-26       Impact factor: 5.214

5.  Brugada Syndrome and Early Repolarisation: Distinct Clinical Entities or Different Phenotypes of the Same Genetic Disease?

Authors:  Giulio Conte; Maria Luce Caputo; François Regoli; Tiziano Moccetti; Pedro Brugada; Angelo Auricchio
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 6.  Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.

Authors:  Carol Ann Remme
Journal:  J Physiol       Date:  2013-07-01       Impact factor: 5.182

7.  Diagnostic Yield of Genetic Testing in Sudden Cardiac Death with Autopsy Findings of Uncertain Significance.

Authors:  Mercedes Iglesias; Tomas Ripoll-Vera; Consuelo Perez-Luengo; Ana Belen García; Susana Moyano; Juan Carlos Canos; Juan Carlos Borondo; Jorge Alvarez; Damian Heine-Suñer; Bernardino Barcelo
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

8.  SNPs identified as modulators of ECG traits in the general population do not markedly affect ECG traits during acute myocardial infarction nor ventricular fibrillation risk in this condition.

Authors:  Raha Pazoki; Jonas S S G de Jong; Roos F Marsman; Nienke Bruinsma; Lukas R C Dekker; Arthur A M Wilde; Connie R Bezzina; Michael W T Tanck
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.

Authors:  Connie R Bezzina; Julien Barc; Yuka Mizusawa; Carol Ann Remme; Jean-Baptiste Gourraud; Floriane Simonet; Arie O Verkerk; Peter J Schwartz; Lia Crotti; Federica Dagradi; Pascale Guicheney; Véronique Fressart; Antoine Leenhardt; Charles Antzelevitch; Susan Bartkowiak; Martin Borggrefe; Rainer Schimpf; Eric Schulze-Bahr; Sven Zumhagen; Elijah R Behr; Rachel Bastiaenen; Jacob Tfelt-Hansen; Morten Salling Olesen; Stefan Kääb; Britt M Beckmann; Peter Weeke; Hiroshi Watanabe; Naoto Endo; Tohru Minamino; Minoru Horie; Seiko Ohno; Kanae Hasegawa; Naomasa Makita; Akihiko Nogami; Wataru Shimizu; Takeshi Aiba; Philippe Froguel; Beverley Balkau; Olivier Lantieri; Margherita Torchio; Cornelia Wiese; David Weber; Rianne Wolswinkel; Ruben Coronel; Bas J Boukens; Stéphane Bézieau; Eric Charpentier; Stéphanie Chatel; Aurore Despres; Françoise Gros; Florence Kyndt; Simon Lecointe; Pierre Lindenbaum; Vincent Portero; Jade Violleau; Manfred Gessler; Hanno L Tan; Dan M Roden; Vincent M Christoffels; Hervé Le Marec; Arthur A Wilde; Vincent Probst; Jean-Jacques Schott; Christian Dina; Richard Redon
Journal:  Nat Genet       Date:  2013-07-21       Impact factor: 38.330

10.  AKAP9 is a genetic modifier of congenital long-QT syndrome type 1.

Authors:  Carin P de Villiers; Lize van der Merwe; Lia Crotti; Althea Goosen; Alfred L George; Peter J Schwartz; Paul A Brink; Johanna C Moolman-Smook; Valerie A Corfield
Journal:  Circ Cardiovasc Genet       Date:  2014-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.